Chinese Biopharmaceutical Association-Usa Inc is located in Potomac, MD. The organization was established in 2008. According to its NTEE Classification (H92) the organization is classified as: Biomedicine & Bioengineering Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Chinese Biopharmaceutical Association-Usa Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Chinese Biopharmaceutical Association-Usa Inc generated $123.3k in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 5.7% each year. All expenses for the organization totaled $141.2k during the year ending 12/2023. While expenses have increased by 12.1% per year over the past 9 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
HOLD CONFERENCES, MEETINGS, WORKSHOPS, AND ACTIVITIES TO FACILITATE COLLABORATION AMONG SCIENTISTS, ENGINEERS AND OTHER RELATED PROFESSIONALS IN BIOPHARMACEUTICAL FIELD
Describe the Organization's Program Activity:
Part 3 - Line 4a
HOLD CONFERENCES, MEETINGS, WORKSHOPS, AND ACTIVITIES TO FACILITATE COLLABORATION AMONG SCIENTISTS, ENGINEERS AND OTHER RETLATED PROFESSIONALS IN BIOPHARMACEUTICAL FIELD.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
You Li Director | Trustee | 1 | $0 |
Steve Chen Director | Trustee | 1 | $0 |
Li Li Director | Trustee | 1 | $0 |
Monica Zhang Director | Trustee | 1 | $0 |
Hao Li Director | Trustee | 1 | $0 |
Qi Zeng Director | Trustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $123,086 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $123,086 |
Total Program Service Revenue | $0 |
Investment income | $208 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $123,294 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $800 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $7,254 |
Advertising and promotion | $3,990 |
Office expenses | $75 |
Information technology | $5,336 |
Royalties | $0 |
Occupancy | $0 |
Travel | $668 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $5,000 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $0 |
All other expenses | $0 |
Total functional expenses | $141,241 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $31,505 |
Savings and temporary cash investments | $650,000 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $681,505 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $0 |
Net assets without donor restrictions | $0 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $681,505 |
Total liabilities and net assets/fund balances | $681,505 |
Organization Name | Assets | Revenue |
---|---|---|
Foundation For The National Institute Of Health Inc North Bethesda, MD | $206,113,368 | $60,965,788 |
Global Genomics And Bioinformatics Research Institute Fairfax, VA | $118,445,508 | $288,537 |
Institute For Gene And Cell Therapies Washington, DC | $538,185 | $1,325,000 |
Foundation For Biomedical Research Washington, DC | $17,068,301 | $3,400,871 |
Gardp North America Inc Philadelphia, PA | $112,657 | $3,137 |
Chinese Biopharmaceutical Association-Usa Inc Potomac, MD | $681,505 | $123,294 |
Center For Genetics Nutrition And Health Inc Washington, DC | $147,617 | $0 |
International Society For Hyaluronan Sciences Wilmington, DE | $360,856 | $102,530 |